Success Metrics

Clinical Success Rate
86.9%

Based on 259 completed trials

Completion Rate
87%(259/298)
Active Trials
32(8%)
Results Posted
36%(93 trials)
Terminated
39(10%)

Phase Distribution

Ph early_phase_1
7
2%
Ph not_applicable
101
25%
Ph phase_1
26
6%
Ph phase_3
62
15%
Ph phase_2
55
13%
Ph phase_4
147
36%

Phase Distribution

33

Early Stage

55

Mid Stage

209

Late Stage

Phase Distribution398 total trials
Early Phase 1First-in-human
7(1.8%)
Phase 1Safety & dosage
26(6.5%)
Phase 2Efficacy & side effects
55(13.8%)
Phase 3Large-scale testing
62(15.6%)
Phase 4Post-market surveillance
147(36.9%)
N/ANon-phased studies
101(25.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

82.2%

259 of 315 finished

Non-Completion Rate

17.8%

56 ended early

Currently Active

32

trials recruiting

Total Trials

408

all time

Status Distribution
Active(40)
Completed(259)
Terminated(56)
Other(53)

Detailed Status

Completed259
unknown51
Terminated39
Recruiting23
Withdrawn17
Active, not recruiting9

Development Timeline

Analytics

Development Status

Total Trials
408
Active
32
Success Rate
86.9%
Most Advanced
Phase 4

Trials by Phase

Early Phase 17 (1.8%)
Phase 126 (6.5%)
Phase 255 (13.8%)
Phase 362 (15.6%)
Phase 4147 (36.9%)
N/A101 (25.4%)

Trials by Status

completed25963%
terminated3910%
recruiting236%
suspended20%
withdrawn174%
active_not_recruiting92%
not_yet_recruiting82%
unknown5113%

Recent Activity

Clinical Trials (408)

Showing 20 of 408 trialsScroll for more
NCT07442877Phase 2

A Phase 2 Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients for Postoperative Pain Treatment in Orthopedic Surgery

Completed
NCT07778511Not Applicable

How Does the Opioid System Shape Stress and Social Behaviour in Men and Women and What Role Does Childhood Unpredictability Play?

Recruiting
NCT07842861Not Applicable

Morphine Versus Dexmedetomidine as Adjuvants to Bupivacaine in TAP Block in Lower Abdominal Surgeries

Completed
NCT07839273Phase 4

Morphine Versus Fentanyl for Myocardial Protection in Acyanotic Children Undergoing Congenital Open-Heart Surgery

Completed
NCT07786012Phase 4

BUprenorphine Versus Morphine for Postcesarean Analgesia (BUMP)

Not Yet Recruiting
NCT04119037Not Applicable

Cordotomy in Reducing Pain in Patients With Advanced Cancer

Active Not Recruiting
NCT07186426Phase 3

A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients for Postoperative Pain Treatment in Orthopedic Surgery

Completed
NCT07076641Phase 3

Efficacy and Safety of Intravenous Lidocaine Versus Placebo in Patients Receiving Morphine-rachi Analgesia

Not Yet Recruiting
NCT07104097Not Applicable

Comparison Between 2 Techniques for Lumbar-ESPB

Completed
NCT07777029Not Applicable

Subcutaneous Methadone for Cesarean Analgesia: a Non Inferiority Study Using QoR-10

Not Yet Recruiting
NCT07412223Phase 4

Effect of Tegileridine on Postoperative Bowel Function Recovery in Abdominal Surgery

Recruiting
NCT04188418Phase 3

Fentanyl Buccal Tablet or Morphine for Exertional Dyspnea in Cancer Patients

Active Not Recruiting
NCT04011163Phase 2

Vital Signs-Integrated Patient-Assisted Intravenous Opioid Analgesia for Post Surgical Pain

Active Not Recruiting
NCT02804022Phase 2

Vital-signs-integrated Patient-assisted Intravenous Opioid Analgesia

Active Not Recruiting
NCT03427736

Anesthetics and Analgesics in Children

Recruiting
NCT01681264Phase 4

Effect of Guanfacine on Opioid-induced Hyperalgesia (OIH) and Tolerance

Terminated
NCT06186141Phase 4

Nausea and Vomiting in Postoperative Paediatric Patients With Patient-Controlled Analgesia (PCA): Morphine vs Oxycodone

Recruiting
NCT07491146Phase 2

Phase II Clinical Study of the Efficacy and Safety of HSK55718 in the Treatment of Abdominal Postoperative Pain

Recruiting
NCT04246697Phase 4

Multimodal Pain Study in Free Flap Patients

Completed
NCT04214834Phase 3

Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)

Active Not Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
408